IMDX

NASDAQ open

Insight Molecular Diagnostics

1.81 USD
▲+0.15+9.04%
盘后 2.42 0.00%
2026-11-20
市值
$64.47M
市盈率
—
EPS
-1.20
股息率
—
52 周区间
1.50 – 7.51
成交量
997.90K
Beta
1.86
目标价
6.50
52W 低 1.5052W 高 7.51
价格走势

公司简介

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test ...